PharmiWeb.com - Global Pharma News & Resources
14-Aug-2019

Jehangir Hospital, along with its research arm Jehangir Clinical Development Centre (JCDC), is the first hospital in India to bring its patients access to international clinical trials by joining Clinerion’s Patient Network Explorer platform.

  • Patients of Jehangir Clinical Development Centre (JCDC) gain visibility on Patient Network Explorer for matching to international trials run by sponsors around the world.
  • JCDC is the first healthcare institution in India to join Clinerion’s global network of partner hospitals.

 

JCDC is the research arm of Jehangir Hospital, Pune, India. The hospital has over 350 beds, servicing patients throughout Pune and beyond. It has a wide range of disease-area specializations, including, but not limited to: cardiology, oncology, endocrinology, pediatrics, rheumatology, dermatology and infectious diseases. JCDC has over 60 principal investigators and conducts on average 25-30 clinical studies at any point of time.

Clinerion’s Patient Network Explorer helps partner hospitals be visible to pharmaceutical companies seeking suitable patients and sites for their clinical trials. Queries based on trial protocols may be sent to partners to assess the count of eligible patients in their electronic health records. All patient data is de-identified and remains under the control of the hospital and inside its IT infrastructure. However, Clinerion’s patented technology also enables authorized trial staff at the hospital to re-identify the patient for the purpose of trial recruitment, while maintaining strict personal data privacy standards.

“We at JCDC are delighted about partnering with Clinerion as there is an ideal alignment of Clinerion’s innovative technology and our clinical research expertise,” says Pathik Divate, CEO of the JCDC. “We are excited about harnessing the power of this technology to leverage our diverse patient population and bring in further efficiency in patient recruitment.”

“The population of India is significantly under-represented when it comes to participation in clinical research. Patient Network Explorer can cut a path through the forest, leading sponsors to the institutions and clinicians who can support clinical trials at an international level of expertise and facilities. This collaboration with Jehangir is just the first step in enabling a global population of eligible patients which reflects the diversity of the world, itself,” says Ian Rentsch, CEO of Clinerion.

 

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website: www.clinerion.com

Clinerion’s Patient Network Explorer: www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer

For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54

media@clinerion.com

 

About Jehangir Clinical Development Centre (JCDC)

JCDC is an accredited and award-winning clinical research center attached to Jehangir Hospital Pune with experience of over 300 clinical studies. JCDC works with over 60 clients including the Top 10 pharma companies worldwide, nutrition, medical devices, consumer healthcare companies and public health institutions.

JCDC therapeutic areas: oncology, endocrinology, nutrition, pediatrics, rheumatology, psychiatry, dermatology, infectious diseases, pulmonology, gynaecology, cardiology, vaccines etc.

Jehangir Clinical Development Centre (JCDC) website: www.jcdc.co.in

For more information, please contact:

Pathik Divate

CEO, JCDC

Jehangir Hospital, 32 Sassoon Road, Pune 411 001, Maharashtra, India.

Tel.: +91-20-6726-8800

pathik@jcdc.co.in

Jehangir Hospital, along with its research arm Jehangir Clinical Development Centre (JCDC), is the first hospital in India to bring its patients access to international clinical trials by joining Clinerion’s Patient Network Explorer platform.

Editor Details

Related Links

Last Updated: 15-Aug-2019